HCPLive

Neurology - Page 4
The MD Magazine Neurology - Page 4 specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Conditions

Conferences

Latest CME

Latest Headlines

Siponimod Significantly Reduces Disability Progression Risk in SPMS
Researchers have evaluated siponimod's efficacy in treating secondary progressive multiple sclerosis (SPMS) in a phase 3 trial.
At the moment the best way to get a diagnosis of multiple sclerosis is through a brain scan. A team in Tennessee is working to improve that with a blood test that could find the condition sooner allowing for treatment to begin faster.
As the leading minds in the field of multiple sclerosis came together in London for the annual ECTRIMS conference the end of the conference brought a considerable amount of excitement in everything from the relapsing form to progressive forms.
As more and more treatments are approved for patients with multiple sclerosis questions are being answered about their effectiveness long past their approval dates. This is true for many of the medications including lemtrada.
Unlike conditions like multiple sclerosis where there is a considerable amount of knowledge and several available approved treatment options that is not the case for neuromyelitis optica. As a result more work is needed to educate patients about what their treatment will be like.
There are currently no medications approved for the treatment of neuromyelitis optica. However, there are clinical trials underway and more research being done to change that in the coming years.
With multiple medications approved to treat multiple sclerosis there is more work being done to help a larger patient population through the course of disease treatment.
It has been a few years now since Tecfidera was approved by the US Food and Drug Administration. In that time there has bee continued research which has shown positive results for patients.
Are patients worse off if they are diagnosed with multiple sclerosis at a younger age? That’s what Italian researchers aimed to make more clear at ECTRIMS 2016.

Most Popular in Neurology - Page 4

Recent Published Journal

@MDMagazine

$vacMongoViewPlus$ $vAR$